Complete Filing Data
Keros Therapeutics, Inc. reported Stockholders Equity of $303.13 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Keros Therapeutics, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Net Income Loss | $87.0M | -$187.4M | -$153.0M | -$104.7M | -$58.7M | -$45.4M | -$12.3M |
| Research And Development Expense | $129.6M | $173.6M | $135.3M | $87.3M | $55.1M | $33.9M | $17.4M |
| Other Nonoperating Income Expense | -$539.0K | -$954.0K | -$206.0K | -$613.0K | -$383.0K | $160.0K | $241.0K |
| Operating Income Loss | $67.6M | -$210.8M | -$169.9M | -$114.8M | -$56.4M | -$46.7M | -$10.6M |
| Operating Expenses | $176.5M | $214.4M | $170.1M | $114.8M | $76.5M | $46.7M | $20.6M |
| Nonoperating Income Expense | $24.3M | $23.8M | $16.9M | $10.1M | -$360.0K | $1.1M | -$1.8M |
| Net Income Loss Available To Common Stockholders Basic | $87.0M | -$187.4M | -$153.0M | -$104.7M | -$58.7M | -$45.4M | -$14.1M |
| General And Administrative Expense | $46.8M | $40.8M | $34.8M | $27.5M | $21.3M | $12.8M | $3.2M |
| Revenue From Contract With Customer Excluding Assessed Tax | $244.1M | $3.6M | $151.0K | $0.00 | $20.1M | $0.00 | $10.0M |
| Net Income Loss Available To Common Stockholders Diluted | $87.0M | -$187.4M | -$153.0M | -$104.7M | -$58.7M | -$45.4M | |
| Income Tax Expense Benefit | $4.9M | $300.0K | $0.00 | $0.00 | $2.0M | -$172.0K | $0.00 |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | $91.9M | -$187.1M | -$153.0M | -$104.7M | -$56.7M | -$45.5M | -$12.3M |
| Interest Expense Debt | $0.00 | $0.00 | $1.0K | $4.0K | $6.0K | ||
| Research And Development Incentive Income | $0.00 | $1.2M | $2.4M | $7.1M | $0.00 | $2.5M | $558.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income Loss | -$7.3M | -$30.7M | $148.5M | -$53.0M | -$45.3M | -$43.1M | -$39.4M | -$37.5M | -$35.8M | -$23.5M | -$27.3M | -$24.2M | -$20.3M | -$15.6M | -$15.9M | -$12.0M | -$10.8M | -$11.9M | -$3.5M | -$2.9M | -$3.2M |
| Research And Development Expense | $19.5M | $43.5M | $48.7M | $49.2M | $40.5M | $38.3M | $34.1M | $32.5M | $31.1M | $21.0M | $23.3M | $18.1M | $14.8M | $10.0M | $11.5M | $8.4M | $7.3M | $8.5M | $3.9M | $4.5M | $4.9M |
| Other Nonoperating Income Expense | -$253.0K | -$221.0K | -$338.0K | -$92.0K | -$196.0K | -$437.0K | -$67.0K | -$155.0K | -$40.0K | $762.0K | $86.0K | -$59.0K | -$137.0K | -$80.0K | -$65.0K | -$86.0K | $158.0K | -$68.0K | $15.0K | $69.0K | $101.0K |
| Operating Income Loss | -$15.4M | -$39.8M | $152.0M | -$58.7M | -$50.4M | -$48.5M | -$43.3M | -$41.3M | -$38.9M | -$28.0M | -$30.7M | -$24.1M | -$20.2M | -$15.5M | -$15.8M | -$11.9M | -$10.9M | -$10.5M | -$2.3M | -$2.7M | -$2.9M |
| Operating Expenses | $29.6M | $58.0M | $59.2M | $59.0M | $50.5M | $48.6M | $43.3M | $41.3M | $38.9M | $28.0M | $30.7M | $24.1M | $20.2M | $15.6M | $15.8M | $11.9M | $10.9M | $10.5M | $4.8M | $5.2M | $5.4M |
| Nonoperating Income Expense | $6.7M | $6.9M | $6.5M | $5.7M | $5.2M | $5.4M | $3.8M | $3.8M | $3.1M | $4.5M | $3.5M | -$60.0K | -$138.0K | -$81.0K | -$66.0K | -$88.0K | $157.0K | -$1.6M | -$1.2M | -$202.0K | -$325.0K |
| Net Income Loss Available To Common Stockholders Basic | -$7.3M | -$30.7M | $148.5M | -$53.0M | -$45.3M | -$43.1M | -$39.4M | -$37.5M | -$35.8M | -$23.5M | -$27.3M | -$24.2M | -$20.3M | -$15.6M | -$15.9M | -$12.0M | -$11.0M | -$12.7M | -$4.0M | -$3.3M | -$3.6M |
| General And Administrative Expense | $10.1M | $14.5M | $10.5M | $9.8M | $10.0M | $10.3M | $9.1M | $8.8M | $7.8M | $6.9M | $7.4M | $6.0M | $5.4M | $5.7M | $4.3M | $3.6M | $3.7M | $2.0M | $972.0K | $654.0K | $491.0K |
| Revenue From Contract With Customer Excluding Assessed Tax | $14.3M | $18.2M | $211.2M | $388.0K | $37.0K | $83.0K | $8.0K | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $100.0K | $0.00 | $0.00 | $0.00 | $2.5M | $2.5M | $2.5M | ||
| Net Income Loss Available To Common Stockholders Diluted | -$7.3M | -$30.7M | $148.5M | -$53.0M | -$45.3M | -$43.1M | -$39.4M | -$37.5M | -$35.8M | -$23.5M | -$27.3M | -$24.2M | -$20.3M | -$15.6M | -$15.9M | -$12.0M | -$11.0M | ||||
| Income Tax Expense Benefit | -$1.4M | -$2.2M | $10.0M | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | -$38.0K | $0.00 | $50.0K | $0.00 | $0.00 | -$172.0K | $0.00 | $0.00 | $0.00 | |||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$8.7M | -$32.9M | $158.5M | -$53.0M | -$45.3M | -$43.1M | -$23.5M | -$27.3M | -$24.2M | -$20.3M | -$15.6M | -$15.8M | -$12.0M | -$10.8M | -$12.1M | -$3.5M | -$2.9M | -$3.2M | |||
| Interest Expense Debt | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $1.0K | $1.0K | $1.0K | $1.0K | $2.0K | $1.0K | $2.0K | $3.0K | $2.0K | $2.0K | ||||||
| Research And Development Incentive Income | $0.00 | $0.00 | $3.7M | $3.4M | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $378.0K | $180.0K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $303.1M | $571.6M | $332.2M | $277.4M | $243.2M | $261.7M | -$19.4M | -$7.2M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $288.9M | $561.4M | $332.4M | $280.4M | $231.4M | $266.0M | $7.1M | $23.4M |
| Cash And Cash Equivalents At Carrying Value | $287.4M | $559.9M | $331.1M | $279.0M | $230.0M | $265.9M | $7.0M | |
| Operating Lease Right Of Use Asset Amortization Expense | $2.4M | $1.8M | $1.6M | $941.0K | $520.0K | $327.0K | $230.0K | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$272.5M | $229.0M | $52.0M | $49.0M | -$34.6M | $258.9M | -$16.3M | |
| Operating Lease Right Of Use Asset | $16.8M | $19.3M | $15.3M | $15.5M | $1.1M | $878.0K | $1.2M | |
| Retained Earnings Accumulated Deficit | -$481.8M | -$568.8M | -$381.4M | -$228.4M | -$123.8M | -$65.0M | -$19.7M | |
| Restricted Cash Noncurrent | $1.4M | $1.4M | $1.2M | $1.3M | $1.3M | $115.0K | $115.0K | |
| Property Plant And Equipment Net | $4.3M | $4.2M | $4.1M | $2.0M | $1.3M | $724.0K | $708.0K | |
| Prepaid Expense And Other Assets Current | $22.2M | $26.2M | $16.0M | $6.7M | $3.4M | $1.9M | $381.0K | |
| Operating Lease Liability Noncurrent | $14.5M | $16.9M | $13.4M | $12.8M | $231.0K | $476.0K | $899.0K | |
| Operating Lease Liability Current | $2.4M | $2.0M | $1.0M | $455.0K | $862.0K | $423.0K | $376.0K | |
| Liabilities Current | $20.4M | $27.5M | $24.4M | $16.5M | $11.8M | $7.2M | $4.5M | |
| Liabilities And Stockholders Equity | $338.0M | $615.9M | $370.0M | $306.8M | $255.3M | $269.4M | $11.0M | |
| Liabilities | $34.9M | $44.3M | $37.8M | $29.4M | $12.1M | $7.7M | $10.5M | |
| Common Stock Value | $4.0K | $4.0K | $3.0K | $2.0K | $2.0K | $2.0K | $1.0K | |
| Assets Current | $315.4M | $588.9M | $347.3M | $285.8M | $251.4M | $267.7M | $8.9M | |
| Assets | $338.0M | $615.9M | $370.0M | $306.8M | $255.3M | $269.4M | $11.0M | |
| Accrued Liabilities Current | $16.0M | $20.9M | $17.9M | $12.8M | $7.3M | $4.6M | $2.0M | |
| Accounts Payable Current | $2.0M | $4.6M | $5.5M | $3.3M | $3.6M | $2.1M | $2.1M | |
| Restricted Cash | $1.4M | $1.4M | $1.2M | $1.3M | $1.3M | $115.0K | ||
| Gain Loss On Sale Of Property Plant Equipment | $13.0K | $0.00 | -$4.0K | -$12.0K | -$46.0K | $0.00 | ||
| Other Assets Noncurrent | $0.00 | $2.1M | $2.1M | $2.1M | $82.0K | $0.00 | ||
| Right Of Use Asset Obtained In Exchange For Operating Lease Liability | $0.00 | $5.7M | $1.3M | $15.4M | $0.00 | $44.0K | $700.0K | |
| Right To Use Assets And Operating Lease Liabilities | $2.0M | $1.3M | -$384.0K | $3.7M | $597.0K | |||
| Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings | $0.00 | -$1.5M | -$2.6M | |||||
| Accounts Receivable Net Current | $3.6M | $2.7M | $143.0K | $0.00 | $18.0M | $0.00 | ||
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $703.6M | $706.7M | $728.9M | $532.8M | $420.9M | $453.9M | $295.8M | $326.3M | $355.0M | $241.0M | $211.2M | $223.5M | $218.5M | $235.7M | $248.4M | $130.8M | $141.4M | -$24.9M | -$16.7M | -$13.2M | -$10.4M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $694.9M | $691.7M | $722.0M | $532.1M | $407.1M | $443.7M | $289.1M | $323.4M | $352.8M | $240.8M | $216.9M | $229.9M | $222.7M | $237.2M | $255.3M | $133.9M | $144.8M | $54.6M | $12.6M | $15.7M | $20.9M |
| Cash And Cash Equivalents At Carrying Value | $693.5M | $690.2M | $720.5M | $530.7M | $405.9M | $442.4M | $287.9M | $322.0M | $351.4M | $239.4M | $215.6M | $228.6M | $221.3M | $237.1M | $255.2M | $133.8M | $144.7M | $54.5M | $12.5M | $15.5M | $20.7M |
| Operating Lease Right Of Use Asset Amortization Expense | $584.0K | $339.0K | $522.0K | $203.0K | $99.0K | $89.0K | $49.0K | ||||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $160.6M | $111.3M | $72.4M | -$1.5M | -$10.7M | $47.5M | -$2.5M | ||||||||||||||
| Operating Lease Right Of Use Asset | $17.5M | $18.1M | $18.7M | $19.8M | $14.6M | $15.0M | $15.7M | $16.0M | $16.4M | $447.0K | $658.0K | $864.0K | $1.3M | $676.0K | $779.0K | $976.0K | $1.0M | $1.1M | |||
| Retained Earnings Accumulated Deficit | -$458.3M | -$451.0M | -$420.3M | -$522.8M | -$469.8M | -$424.5M | -$341.2M | -$301.7M | -$264.2M | -$198.7M | -$175.2M | -$147.9M | -$116.8M | -$96.5M | -$80.9M | -$54.3M | -$42.3M | -$31.5M | |||
| Restricted Cash Noncurrent | $1.4M | $1.4M | $1.4M | $1.4M | $1.2M | $1.2M | $1.2M | $1.3M | $1.3M | $1.3M | $1.3M | $1.3M | $1.3M | $115.0K | $115.0K | $115.0K | $115.0K | $115.0K | |||
| Property Plant And Equipment Net | $4.6M | $4.8M | $4.5M | $4.4M | $4.3M | $4.4M | $3.4M | $3.1M | $2.9M | $1.7M | $1.7M | $1.5M | $1.3M | $1.3M | $854.0K | $739.0K | $781.0K | $822.0K | |||
| Prepaid Expense And Other Assets Current | $22.3M | $26.8M | $21.7M | $21.0M | $26.8M | $20.5M | $16.5M | $12.3M | $10.8M | $6.4M | $6.7M | $2.6M | $4.7M | $4.2M | $779.0K | $2.6M | $3.8M | $1.2M | |||
| Operating Lease Liability Noncurrent | $15.1M | $15.7M | $16.3M | $17.4M | $12.9M | $13.2M | $13.7M | $14.0M | $14.0M | $0.00 | $0.00 | $0.00 | $453.0K | $242.0K | $361.0K | $586.0K | $692.0K | $797.0K | |||
| Operating Lease Liability Current | $2.3M | $2.2M | $2.1M | $1.9M | $1.1M | $1.1M | $611.0K | $0.00 | $0.00 | $455.0K | $670.0K | $884.0K | $843.0K | $449.0K | $436.0K | $412.0K | $400.0K | $388.0K | |||
| Liabilities Current | $24.1M | $34.7M | $39.4M | $29.0M | $21.2M | $18.7M | $16.7M | $16.1M | $15.5M | $11.5M | $15.5M | $11.6M | $11.0M | $7.5M | $9.0M | $6.8M | $8.3M | $8.8M | |||
| Liabilities And Stockholders Equity | $742.8M | $757.2M | $784.6M | $579.3M | $455.0M | $485.8M | $326.2M | $356.3M | $384.4M | $252.6M | $226.7M | $235.1M | $230.0M | $243.5M | $257.7M | $138.2M | $150.4M | $60.6M | |||
| Liabilities | $39.2M | $50.4M | $55.7M | $46.4M | $34.1M | $31.9M | $30.4M | $30.0M | $29.5M | $11.5M | $15.5M | $11.6M | $11.5M | $7.8M | $9.4M | $7.5M | $9.1M | $9.7M | |||
| Common Stock Value | $4.0K | $4.0K | $4.0K | $4.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $1.0K | |||
| Assets Current | $719.3M | $732.8M | $759.5M | $552.0M | $432.7M | $463.1M | $304.4M | $334.3M | $362.2M | $245.9M | $222.4M | $231.2M | $226.1M | $241.4M | $256.0M | $136.4M | $148.5M | $58.5M | |||
| Assets | $742.8M | $757.2M | $784.6M | $579.3M | $455.0M | $485.8M | $326.2M | $356.3M | $384.4M | $252.6M | $226.7M | $235.1M | $230.0M | $243.5M | $257.7M | $138.2M | $150.4M | $60.6M | |||
| Accrued Liabilities Current | $15.2M | $20.0M | $17.3M | $22.2M | $13.6M | $12.7M | $12.2M | $11.9M | $10.8M | $8.4M | $7.1M | $7.7M | $7.4M | $5.7M | $5.5M | $4.7M | $3.0M | $6.0M | |||
| Accounts Payable Current | $2.3M | $5.3M | $6.6M | $5.0M | $6.5M | $5.0M | $3.9M | $4.1M | $4.7M | $2.7M | $7.7M | $3.1M | $2.8M | $1.4M | $3.0M | $1.7M | $4.9M | $2.4M | |||
| Restricted Cash | $1.4M | $1.4M | $1.4M | $1.4M | $1.2M | $1.2M | $1.2M | $1.3M | $1.3M | $1.3M | $1.3M | $1.3M | $1.3M | $115.0K | $115.0K | $115.0K | $115.0K | $115.0K | $115.0K | $131.0K | $131.0K |
| Gain Loss On Sale Of Property Plant Equipment | $0.00 | -$4.0K | $0.00 | ||||||||||||||||||
| Other Assets Noncurrent | $0.00 | $0.00 | $463.0K | $1.6M | $2.2M | $2.1M | $1.6M | $1.6M | $1.6M | $3.2M | $667.0K | $275.0K | |||||||||
| Right Of Use Asset Obtained In Exchange For Operating Lease Liability | $0.00 | $1.3M | $0.00 | ||||||||||||||||||
| Right To Use Assets And Operating Lease Liabilities | $448.0K | $240.0K | $82.0K | $402.0K | |||||||||||||||||
| Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | -$1.5M | -$1.2M | -$647.0K | -$604.0K | ||||||||||||
| Accounts Receivable Net Current | $3.5M | $15.8M | $17.3M | $388.0K | $4.0K | $226.0K | $0.00 | $0.00 | $0.00 | $100.0K | |||||||||||
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Share Based Compensation | $28.7M | $34.9M | $28.8M | $18.7M | $11.7M | $4.1M | $59.0K |
| Proceeds From Stock Options Exercised | $150.0K | $12.1M | $3.2M | $818.0K | $379.0K | $38.0K | $14.0K |
| Payments To Acquire Property Plant And Equipment | $1.6M | $1.9M | $2.5M | $1.2M | $1.0M | $294.0K | $271.0K |
| Net Cash Provided By Used In Operating Activities | $107.5M | -$160.9M | -$124.5M | -$70.1M | -$62.1M | -$36.9M | -$16.0M |
| Net Cash Provided By Used In Investing Activities | -$1.6M | -$1.9M | -$2.5M | -$1.2M | -$1.0M | -$294.0K | -$271.0K |
| Net Cash Provided By Used In Financing Activities | -$378.5M | $391.8M | $179.0M | $120.3M | $28.6M | $296.0M | $14.0K |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$4.0M | $10.2M | $9.3M | $3.3M | $1.5M | $1.5M | -$1.9M |
| Increase Decrease In Accrued Liabilities | -$10.1M | $3.0M | $5.3M | $5.3M | $2.7M | $2.6M | $1.2M |
| Increase Decrease In Accounts Payable | -$3.0M | -$249.0K | $1.6M | -$408.0K | $1.5M | $61.0K | $1.3M |
| Increase Decrease In Accounts Receivable | $825.0K | $2.6M | $143.0K | -$18.0M | $18.0M | $0.00 | |
| Increase Decrease In Other Noncurrent Liabilities | $0.00 | $0.00 | -$62.0K | -$57.0K | -$53.0K | ||
| Payments Of Stock Issuance Costs | $0.00 | $171.0K | $94.0K | $87.0K | $227.0K | $0.00 | |
| Increase Decrease In Other Operating Assets | -$2.1M | $4.0K | $478.0K | $1.6M | $0.00 | ||
| Increase Decrease In Operating Lease Liability | -$597.0K | -$376.0K | -$213.0K | ||||
| Proceeds From Issuance Initial Public Offering | $0.00 | $102.7M | $0.00 | ||||
| Proceeds From Issuance Of Convertible Preferred Stock | $0.00 | $56.0M | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 | Q4 2020 | Q1 2020 | Q1 2019 |
|---|---|---|---|---|---|---|---|---|
| Share Based Compensation | $8.9M | $8.1M | $5.7M | $4.4M | $2.5M | $12.0K | $11.0K | |
| Proceeds From Stock Options Exercised | $4.0K | $5.7M | $370.0K | $118.0K | $42.0K | $13.0K | $0.00 | |
| Payments To Acquire Property Plant And Equipment | $565.0K | $946.0K | $1.1M | $147.0K | $210.0K | $176.0K | $0.00 | |
| Net Cash Provided By Used In Operating Activities | $161.2M | -$44.6M | -$34.2M | -$1.4M | -$10.5M | -$8.1M | -$2.5M | |
| Net Cash Provided By Used In Investing Activities | -$565.0K | -$946.0K | -$1.1M | -$147.0K | -$210.0K | -$176.0K | $0.00 | |
| Net Cash Provided By Used In Financing Activities | $4.0K | $156.8M | $107.7M | $118.0K | $42.0K | $55.8M | $0.00 | |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$4.5M | $4.5M | $4.1M | -$764.0K | -$1.1M | $816.0K | -$1.7M | |
| Increase Decrease In Accrued Liabilities | -$3.6M | -$5.4M | -$2.0M | $361.0K | $894.0K | $3.3M | $177.0K | |
| Increase Decrease In Accounts Payable | $2.0M | $23.0K | $1.3M | -$668.0K | $859.0K | -$193.0K | $813.0K | |
| Increase Decrease In Accounts Receivable | $14.5M | $83.0K | $0.00 | -$18.0M | $0.00 | |||
| Increase Decrease In Other Noncurrent Liabilities | $0.00 | -$15.0K | -$15.0K | -$12.0K | ||||
| Payments Of Stock Issuance Costs | $9.9M | $0.00 | $219.0K | $0.00 | ||||
| Increase Decrease In Other Operating Assets | -$1.6M | $0.00 | ||||||
| Increase Decrease In Operating Lease Liability | -$402.0K | -$102.0K | -$90.0K | -$50.0K | ||||
| Proceeds From Issuance Initial Public Offering | $149.5M | $110.4M | ||||||
| Proceeds From Issuance Of Convertible Preferred Stock | $0.00 | $56.0M | $0.00 |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Diluted EPS * | $2.30 | -$5.00 | -$5.20 | -$4.15 | -$2.52 | -$2.93 | -$6.08 |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Weighted Average Number Of Shares Outstanding Basic | 37.2M | 37.4M | 29.4M | 25.2M | 23.3M | 15.5M | |
| Weighted Average Number Of Diluted Shares Outstanding | 37.9M | 37.4M | 29.4M | 25.2M | 23.3M | 15.5M | |
| Earnings Per Share Basic | $2.34 | $-5.00 | $-5.20 | $-4.15 | $-2.52 | $-2.93 | |
| Common Stock Shares Outstanding | 19.5M | 40.6M | 31.8M | 27.5M | 24.0M | 23.2M | 2.4M |
| Common Stock Shares Issued | 40.7M | 40.6M | 31.8M | 27.5M | 24.0M | 23.2M | 2.4M |
| Common Stock Shares Authorized | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 27.0M |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | |||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 15.5M | 2.3M | |||||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.18 | -$0.76 | $3.62 | -$1.41 | -$1.25 | -$1.21 | -$1.33 | -$1.27 | -$1.26 | -$0.92 | -$1.13 | -$1.01 | -$0.87 | -$0.67 | -$0.68 | -$0.60 | -$0.62 | -$5.11 | -$1.71 | -$1.44 | -$1.61 |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Weighted Average Number Of Shares Outstanding Basic | 40.6M | 40.6M | 40.6M | 37.6M | 36.1M | 35.7M | 29.7M | 29.6M | 28.4M | 25.5M | 24.1M | 24.0M | 23.4M | 23.3M | 23.2M | 20.2M | 17.6M | ||||
| Weighted Average Number Of Diluted Shares Outstanding | 40.6M | 40.6M | 41.0M | 37.6M | 36.1M | 35.7M | 29.7M | 29.6M | 28.4M | 25.5M | 24.1M | 24.0M | 23.4M | 23.3M | 23.2M | 20.2M | 17.6M | ||||
| Earnings Per Share Basic | $-0.18 | $-0.76 | $3.66 | $-1.41 | $-1.25 | $-1.21 | $-1.33 | $-1.27 | $-1.26 | $-0.92 | $-1.13 | $-1.01 | $-0.87 | $-0.67 | $-0.68 | $-0.60 | $-0.62 | ||||
| Common Stock Shares Outstanding | 40.6M | 40.6M | 40.6M | 39.3M | 36.2M | 36.1M | 29.7M | 29.7M | 29.5M | 26.1M | 24.4M | 24.0M | 23.4M | 23.3M | 23.3M | 20.2M | 20.2M | 2.5M | |||
| Common Stock Shares Issued | 40.6M | 40.6M | 40.6M | 39.3M | 36.2M | 36.1M | 29.7M | 29.7M | 29.5M | 26.1M | 24.4M | 24.0M | 23.4M | 23.3M | 23.3M | 20.2M | 20.2M | 2.5M | |||
| Common Stock Shares Authorized | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 35.0M | |||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||||||||||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 23.2M | 20.2M | 17.6M | 2.5M | 2.3M | 2.3M | 2.3M | ||||||||||||||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||||||||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||||||||
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $28.7M | $34.9M | $28.8M | $18.7M | $11.7M | $4.1M | $59.0K |
| Stock Issued During Period Value Stock Options Exercised | $150.0K | $12.1M | $3.2M | $818.0K | $379.0K | $38.0K | $14.0K |
| Depreciation | $1.5M | $1.2M | $815.0K | $674.0K | $378.0K | $278.0K | $208.0K |
| Additional Paid In Capital | $1.17B | $1.14B | $713.6M | $505.9M | $366.9M | $326.7M | $203.0K |
| Capital Expenditures Incurred But Not Yet Paid | $5.0K | $0.00 | $599.0K | $75.0K | $11.0K | $0.00 | |
| Payment Of Initial Public Offering Costs | $0.00 | $283.0K | $0.00 | $0.00 | $0.00 | $2.5M | $0.00 |
| Dividend Income Operating | $24.9M | $23.5M | $14.8M | $3.6M | $27.0K | ||
| Stock Issued During Period Shares Stock Options Exercised | 73.7K | 398.5K | 236.0K | 158.2K | 262.0K | 113.5K | |
| Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures | $0.00 | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $4.0M | $8.5M | $8.9M | $8.8M | $8.8M | $8.1M | $8.7M | $7.0M | $5.7M | $4.8M | $4.8M | $4.4M | $3.1M | $2.8M | $2.5M | $1.4M | $1.1M | $12.0K | $17.0K | $13.0K | $11.0K |
| Stock Issued During Period Value Stock Options Exercised | $2.0K | $17.0K | $4.0K | $1.0M | $3.0M | $5.7M | $311.0K | $1.7M | $370.0K | $96.0K | $502.0K | $118.0K | $35.0K | $57.0K | $42.0K | $9.0K | $9.0K | $13.0K | $7.0K | $3.0K | |
| Depreciation | $344.0K | $277.0K | $167.0K | $113.0K | $80.0K | $63.0K | $45.0K | ||||||||||||||
| Additional Paid In Capital | $1.16B | $1.16B | $1.15B | $1.06B | $890.7M | $878.5M | $637.0M | $628.0M | $619.2M | $439.7M | $386.4M | $371.4M | $335.3M | $332.2M | $329.3M | $185.1M | $183.7M | $6.7M | |||
| Capital Expenditures Incurred But Not Yet Paid | $15.0K | $230.0K | $21.0K | $87.0K | $0.00 | ||||||||||||||||
| Payment Of Initial Public Offering Costs | $0.00 | $259.0K | $0.00 | ||||||||||||||||||
| Dividend Income Operating | $6.9M | $7.1M | $6.8M | $5.8M | $5.4M | $5.8M | $3.9M | $4.0M | $3.1M | ||||||||||||
| Stock Issued During Period Shares Stock Options Exercised | 7.3K | 201.7K | 14.3K | 28.3K | 78.6K | 44.7K | |||||||||||||||
| Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Most recent annual filing with the SEC: March 4, 2026
Data sourced from SEC EDGAR public filings as of August 7, 2026.